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INTRODUCTION: Bifacial weakness with paresthesia is a rare subtype of Guillain-Barré syndrome (GBS).
1, 2 Generally, facial paralysis is transient 3 and may recover completely with proper treatment. 4 We describe a case of facial muscle contracture with synkinetic movement, resulting from GBS. Botulinum toxin A was effective to control these sequelae.
CASE PRESENTATION:
A 29-years-old female was referred to us with a bilateral facial muscle contracture at rest and synkinetic movement after treatment of GBS. The contracture was seen in the whole face including the forehead, glabella, eye, cheek, upper lip, and mentum region.
Botulinum toxin A was used to suppress the facial muscle contractures and control the synkinetic facial movement. Although complete recovery could not achieved, the injection was effective. Now the patient has been undergoing the injections repeatedly with no adverse effect.
CONCLUSION:
Facial muscle contracture due to GBS is well controlled by botulinum toxin A injections. However according to recovering of the facial functions, it is insufficient to treat only by botulinum toxin A injections. 
INTRODUCTION:
It has been reported that 88% of women who had breast augmentation surgery had preoperative breast asymmetry. 1-2 However, the prevalence of breast asymmetry has not been well studied in women undergoing other types of breast surgeries.
METhOD: Breast measurements of women, who did not have prior breast surgery, were prospectively recorded in a plastic surgery database. The women in the study had been consecutively evaluated for possible plastic surgery of the breast area. They were classified into three groups according to the presenting breast problem; hypoplastic breasts, macromastia, and ptotic breasts. Comparisons were made between the right and left side of each patient, regarding symmetry of the nipple-areola complex (size and position), breast mound, and chest wall. Differences between groups were evaluated using the Chi2 test and values of p<0.05 were considered statistically significant.
RESULTS:
The breast measurements of 244 women who were consecutively evaluated were analyzed. The mean age was 34 ± 11 years. The study population was distributed in the following manner: 106 women had hypoplastic breasts, 80 women had macromastia, and 58 women had ptotic breasts. Asymmetry of the size and position of the nippleareola complex was the most common type, being present in 54 ± 12% of women with hypoplastic breasts, 59 ± 15% of women with macromastia and 51 ± 10% of women with ptotic breasts. Asymmetry of the breast mound was found in 45 ± 12% (hypoplasia), 47 ± 10 (macromastia) and 43 ± 11% (ptosis) of the groups. Asymmetry of the chest wall was present in 12 ± 10% (hypoplasia), 11 ± 9 (macromastia) and 10 ± 7% (ptosis) of the groups respectively. Overall, we
